Table of Contents Author Guidelines Submit a Manuscript
Advances in Pharmacological Sciences
Volume 2018, Article ID 1314941, 13 pages
https://doi.org/10.1155/2018/1314941
Research Article

Antidiabetic Effects of the Ethanolic Root Extract of Uvaria chamae P. Beauv (Annonaceae) in Alloxan-Induced Diabetic Rats: A Potential Alternative Treatment for Diabetes Mellitus

1Department of Pharmacology and Therapeutics, College of Medicine, Ambrose Alli University, Ekpoma, Nigeria
2Department of Pharmacology, Therapeutics and Toxicology, College of Medicine, University of Lagos, Lagos, Nigeria

Correspondence should be addressed to Jonathan Emeka Emordi; moc.liamg@idrome.nahtanojrd

Received 29 May 2018; Revised 26 September 2018; Accepted 27 September 2018; Published 8 November 2018

Academic Editor: Robert Gogal

Copyright © 2018 Jonathan Emeka Emordi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. A. Tabish, “Is diabetes becoming the biggest epidemic of the twenty-first century?” International Journal of Health Sciences, vol. 1, no. 2, pp. 5–8, 2007. View at Google Scholar
  2. World Health Organization, Global Health estimates 2013: Deaths by Cause, Age, Sex and Country, 2000-2012, WHO, Geneva, Switzerland, 2014.
  3. F. C. D. Andrade, “Measuring the impact of diabetes on life expectancy and disability-free life expectancy among older adults in Mexico,” Journals of Gerontology Series B: Psychological Sciences and Social Sciences, vol. 65, no. 3, pp. 381–389, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. K. G. M. M. Alberti, P. Z. Zimmet, and WHO Consultation, “Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation,” Diabetic Medicine, vol. 15, no. 7, pp. 539–553, 1998. View at Publisher · View at Google Scholar
  5. American Diabetes Association, “Diagnosis and classification of diabetes mellitus,” Diabetes Care, vol. 33, no. 1, pp. S62–S69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. M. E. Cerf, “Beta cell dysfunction and insulin resistance,” Frontiers in Endocrinology, vol. 4, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. A. D. Deshpande, M. Harris-Hayes, and M. Schootman, “Epidemiology of diabetes and diabetes-related complications,” Physical Therapy, vol. 88, no. 11, pp. 1254–1264, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. J. A. Ray, W. J. Valentine, K. Secnik et al., “Review of the cost of diabetes complications in Australia, Canada, France, Germany, Italy and Spain,” Current Medical Research and Opinion, vol. 21, no. 10, pp. 1617–1629, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. T. Scully, “Diabetes in numbers,” Nature, vol. 485, no. 7398, pp. S2–S3, 2012. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Matsumoto, H. Noguchi, N. Hatanaka et al., “Estimation of donor usability for islet transplantation in the United States with the Kyoto islet isolation method,” Cell Transplantation, vol. 18, no. 5-6, pp. 549–556, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. M. T. Abdel Aziz, M. F. El-Asmar, A. M. Rezq et al., “The effect of a novel curcumin derivative on pancreatic islet regeneration in experimental type-1 diabetes in rats (long term study),” Diabetology and Metabolic Syndrome, vol. 5, no. 1, p. 75, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. X. Xu, G. Wang, T. Zhou, L. Chen, J. Chen, and X. Shen, “Novel approaches to drug discovery for the treatment of type 2 diabetes,” Expert Opinion on Drug Discovery, vol. 9, no. 9, pp. 1047–1058, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Maedler, R. D. Carr, D. Bosco, R. A. Zuellig, T. Berney, and M. Y. Donath, “Sulfonylurea induced β-cell apoptosis in cultured human islets,” Journal of Clinical Endocrinology and Metabolism, vol. 90, no. 1, pp. 501–506, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. S. Del Guerra, L. Marselli, R. Lupi et al., “Effects of prolonged in vitro exposure to sulphonylureas on the function and survival of human islets,” Journal of Diabetes and its Complications, vol. 19, no. 1, pp. 60–64, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. A. A. Tahrani, C. J. Bailey, S. Del Prato, and A. H. Barnett, “Management of type 2 diabetes: new and future developments in treatment,” The Lancet, vol. 378, no. 9786, pp. 182–197, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. J. Meier, “Beta cell mass in diabetes: a realistic therapeutic target?” Diabetologia, vol. 51, no. 5, pp. 703–713, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. M. V. Risbud and R. R. Bhonde, “Models of pancreatic regeneration in diabetes,” Diabetes Research and Clinical Practice, vol. 58, no. 3, pp. 155–165, 2002. View at Publisher · View at Google Scholar · View at Scopus
  18. H.-S. Jun, “Regeneration of pancreatic beta cells,” Frontiers in Bioscience, vol. 13, no. 13, pp. 6170–6182, 2008. View at Publisher · View at Google Scholar
  19. L.-M. Xiu, A. B. Miura, K. Yamamoto et al., “Pancreatic islet regeneration by ephedrine in mice with streptozotocin-induced diabetes,” American Journal of Chinese Medicine, vol. 29, pp. 493–500, 2001. View at Publisher · View at Google Scholar
  20. M. F. Mahomoodally, “Traditional medicines in Africa: an appraisal of ten potent african medicinal plants,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 617459, 14 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. D. E. Okwu and F. Iroabuchi, “Phytochemical composition and biological activities of Uvaria chamae and clerodendoron splendens,” E-Journal of Chemistry, vol. 6, no. 2, pp. 553–560, 2009. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Oluremi, M. Osungunna, and O. Omafuma, “Comparative assessment of antibacterial activity of Uvaria chamae parts,” African Journal of Microbiology Research, vol. 4, no. 13, pp. 1391–1394, 2010. View at Google Scholar
  23. J. E. Emordi, E. O. Agbaje, I. A. Oreagba, and O. I. Iribhogbe, “Antidiabetic and hypolipidemic activities of hydroethanolic root extract of Uvaria chamae in streptozotocin induced diabetic albino rats,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. E. J. Emeka, A. E. Oluwatoyin, O. I. Adekunle, and I. O. Ignis, “Preliminary phytochemical screening and evaluation of hypoglycemic properties of the root extract of Uvaria chamae,” Bangladesh Journal of Pharmacology, vol. 10, no. 2, pp. 326–331, 2015. View at Publisher · View at Google Scholar · View at Scopus
  25. J. E. Okokon, B. N. Ita, and A. E. Udokpoh, “The in-vivo antimalarial activities of Uvaria chamae and Hippocratea africana,” Annals of Tropical Medicine and Parasitology, vol. 100, no. 7, pp. 585–590, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Okwuosa, E. Chukwura, G. Chukwuma et al., “Phytochemical and antifungal activities of Uvaria chamae leaves and roots, Spondias mombin leaves and bark and Combretum racemosum leaves,” African Journal of Medicine and Medical Sciences, vol. 41, pp. 99–103, 2012. View at Google Scholar
  27. V. O. Adelodun, C. A. Elusiyan, F. O. Olorunmola et al., “Evaluation of antitrypanosomal and anti inflammatory activities of selected Nigerian medicinal plants in mice,” African Journal of Traditional, Complementary and Alternative Medicines, vol. 10, no. 6, p. 469, 2013. View at Publisher · View at Google Scholar · View at Scopus
  28. N. R. Council, Guide for the Care and Use of Laboratory Animals, National Academies Press, Washington, DC, USA, 2010.
  29. M. H. Fard, G. Naseh, N. Lotfi, S. M. Hosseini, and M. Hosseini, “Effects of aqueous extract of turnip leaf (Brassica rapa) in alloxan-induced diabetic rats,” Avicenna Journal of Phytomedicine, vol. 5, no. 2, p. 148, 2015. View at Google Scholar
  30. G. B. Migliori, E. Pontali, G. Sotgiu et al., “Combined use of Delamanid and Bedaquiline to treat multidrug-resistant and extensively drug-resistant tuberculosis: a systematic review,” International Journal of Molecular Sciences, vol. 18, no. 2, p. 341, 2017. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Crook, Clinical Chemistry & Metabolic Medicine, Hodder Arnold, London, UK, 2006.
  32. H. Bagheri, F. Michel, M. Lapeyre-Mestre et al., “Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals,” British Journal of Clinical Pharmacology, vol. 50, no. 5, pp. 479–484, 2001. View at Publisher · View at Google Scholar · View at Scopus
  33. M. Hørder, R. Elser, W. Gerhardt, M. Mathieu, and E. Sampson, “Approved recommendation of IFCC methods for the measurement of catalytic concentration of enzymes. VII: IFCC method for creatine kinase (ATP: creatine N-phosphotransferase EC 2.7. 3.2),” European Journal of Clinical Chemistry and Clinical Biochemistry, vol. 29, no. 7, pp. 435–456, 1991. View at Google Scholar
  34. H. E. M. Ali Hussain, “Hypoglycemic, hypolipidemic and antioxidant properties of combination of Curcumin from Curcuma longa, Linn, and partially purified product from Abroma augusta, Linn. in streptozotocin induced diabetes,” Indian Journal of Clinical Biochemistry, vol. 17, no. 2, pp. 33–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. W. E. Grizzle, J. L. Fredenburgh, and R. B. Myers, Fixation of Tissues, Theory and Practice of Histological Techniques, Elsevier, New York, NY, USA, 2008.
  36. M. I. Kazeem, S. M. Ogungbe, G. M. Saibu, and O. M. Aboyade, “In vitro study on the hypoglycemic potential of Nicotiana tabacum leaf extracts,” Bangladesh Journal of Pharmacology, vol. 9, no. 2, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. D. M. Nagmoti and A. R. Juvekar, “In vitro inhibitory effects of Pithecellobium dulce (Roxb.) Benth. seeds on intestinal α-glucosidase and pancreatic α-amylase,” Journal of Biochemical Technology, vol. 4, no. 3, 2013. View at Google Scholar
  38. J. G. Ayisi, A. H. van’t Hoog, J. A. Agaya et al., “Care seeking and attitudes towards treatment compliance by newly enrolled tuberculosis patients in the district treatment programme in rural western Kenya: a qualitative study,” BMC Public Health, vol. 11, no. 1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  39. K. Masur, F. Thévenod, and K. S. Zänker, Diabetes and Cancer: Epidemiological Evidence and Molecular Links, Karger Medical and Scientific Publishers, Basel, Switzerland, 2008.
  40. K. Athanasakis, M. Ollandezos, A. Angeli, A. Gregoriou, M. Geitona, and J. Kyriopoulos, “Estimating the direct cost of type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost,” Diabetic Medicine, vol. 27, no. 6, pp. 679–684, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. O. O. Olaokun, L. J. McGaw, I. J. van Rensburg, J. N. Eloff, and V. Naidoo, “Antidiabetic activity of the ethyl acetate fraction of Ficus lutea (Moraceae) leaf extract: comparison of an in vitro assay with an in vivo obese mouse model,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  42. J. M. Park, H. Y. Bong, H. I. Jeong, Y. K. Kim, J. Y. Kim, and O. Kwon, “Postprandial hypoglycemic effect of mulberry leaf in Goto-Kakizaki rats and counterpart control Wistar rats,” Nutrition Research and Practice, vol. 3, no. 4, p. 272, 2009. View at Publisher · View at Google Scholar
  43. M. F. Mahomoodally, A. H. Subratty, A. Gurib-Fakim, M. I. Choudhary, and S. N. Khan, “Traditional medicinal herbs and food plants have the potential to inhibit key carbohydrate hydrolyzing Enzymes in vitro and reduce postprandial blood glucose peaks in vivo,” Scientific World Journal, vol. 2012, Article ID 285284, 9 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. C. M. N. Picot, A. H. Subratty, and M. F. Mahomoodally, “Inhibitory potential of five traditionally used native antidiabetic medicinal plants on α-amylase, α-glucosidase, glucose entrapment, and amylolysis Kinetics in vitro,” Advances in Pharmacological Sciences, vol. 2014, Article ID 739834, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  45. A. S. Prabhu and G. Ananthan, “Alpha-amylase inhibitory activities of ascidians in the treatment of diabetes mellitus,” Bangladesh Journal of Pharmacology, vol. 9, no. 4, 2014. View at Publisher · View at Google Scholar · View at Scopus
  46. S.-H. Jo, C.-Y. Cho, J.-Y. Lee, K.-S. Ha, Y.-I. Kwon, and E. Apostolidis, “In vitro and in vivo reduction of post-prandial blood glucose levels by ethyl alcohol and water Zingiber mioga extracts through the inhibition of carbohydrate hydrolyzing enzymes,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  47. J. M. Berg and J. Tymoczko, Stryer: Biochemistry, WH Freeman and Company, San Francisco, CA, USA, 2002.
  48. E. Thilagam, B. Parimaladevi, C. Kumarappan, and S. C. Mandal, “α-Glucosidase and α-amylase inhibitory activity of Senna surattensis,” Journal of Acupuncture and Meridian Studies, vol. 6, no. 1, pp. 24–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  49. D. A. Stoffers, “The development of beta-cell mass: recent progress and potential role of GLP-1,” Hormone and Metabolic Research, vol. 36, no. 11-12, pp. 811–821, 2004. View at Publisher · View at Google Scholar · View at Scopus
  50. S. Wang, J. Hecksher-Sorensen, Y. Xu et al., “Myt1 and Ngn3 form a feed-forward expression loop to promote endocrine islet cell differentiation,” Developmental Biology, vol. 317, no. 2, pp. 531–540, 2008. View at Publisher · View at Google Scholar · View at Scopus
  51. Z. C. Feng, J. Li, B. A. Turco, M. Riopel, S. P. Yee, and R. Wang, “Critical role of c-Kit in beta cell function: increased insulin secretion and protection against diabetes in a mouse model,” Diabetologia, vol. 55, no. 8, pp. 2214–2225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  52. B. Thirumalaisamy, S. G. Prabhakaran, K. Marimuthu, and T. K. Chatterjee, “Antihyperlipidemic activity of the ethyl-acetate fraction of stereospermum suaveolens in streptozotocin-induced diabetic rats,” Journal of Pharmacopuncture, vol. 16, no. 3, pp. 23–29, 2013. View at Publisher · View at Google Scholar
  53. J. E. Heidrich, L. M. Contos, L. A. Hunsaker, L. M. Deck, and D. L. Vander Jagt, “Inhibition of pancreatic cholesterol esterase reduces cholesterol absorption in the hamster,” BMC Pharmacology, vol. 4, no. 1, p. 5, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. R. B. Birari and K. K. Bhutani, “Pancreatic lipase inhibitors from natural sources: unexplored potential,” Drug Discovery Today, vol. 12, no. 19-20, pp. 879–889, 2007. View at Publisher · View at Google Scholar · View at Scopus
  55. K. M. Ali, A. Wonnerth, K. Huber, and J. Wojta, “Cardiovascular disease risk reduction by raising HDL cholesterol - current therapies and future opportunities,” British Journal of Pharmacology, vol. 167, no. 6, pp. 1177–1194, 2012. View at Publisher · View at Google Scholar · View at Scopus
  56. H. Chang, Q. Wang, T. Shi et al., “Effect of DanQi Pill on PPARα, lipid disorders and arachidonic acid pathway in rat model of coronary heart disease,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2016. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Adisakwattana, T. Thilavech, and C. Chusak, “Mesona Chinensis Benth extract prevents AGE formation and protein oxidation against fructose-induced protein glycation in vitro,” BMC Complementary and Alternative Medicine, vol. 14, no. 1, 2014. View at Publisher · View at Google Scholar · View at Scopus
  58. H. K. I. Perera, W. K. V. K. Premadasa, and J. Poongunran, “α-glucosidase and glycation inhibitory effects of costus speciosus leaves,” BMC Complementary and Alternative Medicine, vol. 16, no. 1, 2015. View at Publisher · View at Google Scholar · View at Scopus
  59. M. William and B. Stephen, Clinical Chemistry, Mosby Elsevier, Philadelphia, PA, USA, 6th edition, 2008.
  60. J. D. Caisey and D. J. King, “Clinical chemical values for some common laboratory animals,” Clinical Chemistry, vol. 26, no. 13, pp. 1877–1879, 1980. View at Google Scholar
  61. D. D. Woodman, “Assessment of hepatotoxicity,” Animal Clinical Chemistry, A Primer for Toxicologists, G. O. Evans, Ed., Taylor and Francis, London, pp. 71–86, 1996. View at Google Scholar
  62. J. R. Senior, “Monitoring for hepatotoxicity: what is the predictive value of liver “function” tests?” Clinical Pharmacology and Therapeutics, vol. 85, no. 3, pp. 331–334, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. D. F. Williamson, T. J. Thompson, M. Thun, D. Flanders, E. Pamuk, and T. Byers, “Intentional weight loss and mortality among overweight individuals with diabetes,” Diabetes Care, vol. 23, no. 10, pp. 1499–1504, 2000. View at Publisher · View at Google Scholar · View at Scopus
  64. P. Hollander, “Anti-diabetes and anti-obesity medications: effects on weight in people with diabetes,” Diabetes Spectrum, vol. 20, no. 3, pp. 159–165, 2007. View at Publisher · View at Google Scholar · View at Scopus
  65. A. J. Akindele, A. A. Adeneye, O. S. Salau, M. O. Sofidiya, and A. S. Benebo, “Dose and time-dependent sub-chronic toxicity study of hydroethanolic leaf extract of Flabellaria paniculata Cav. (Malpighiaceae) in rodents,” Frontiers in Pharmacology, vol. 5, 2014. View at Publisher · View at Google Scholar · View at Scopus